Novo Nordisk A/S’s blockbuster Ozempic won US approval to treat chronic kidney disease in patients who also have type 2 diabetes, further expanding the popular drug’s use.
Source link
Novo’s Ozempic Notches Approval for Kidney Disease, Widening Use
